The Mount Sinai Health System has opened a center that will combine artificial intelligence with data science and genomics in a location in the center of the Mount Sinai Hospital campus in Manhattan.
The health system said the Hamilton and Amabel James Center for Artificial Intelligence and Human Health is dedicated to improving healthcare delivery through the research, development and application of innovative artificial intelligence tools and technologies. The 12-story, 65,000-square-foot facility will initially house approximately 40 principal investigators, along with 250 graduate students, postdoctoral fellows, computer scientists and support staff.
“By integrating AI technology into genomics, imaging, pathology, electronic health records and more, Mount Sinai is revolutionizing doctors’ ability to diagnose and treat patients, reshaping the future of healthcare. Mount Sinai has been at the forefront of AI research and development in healthcare, and we are now one of the first medical schools to establish a dedicated AI research center,” said Eric Nestler, MD, Ph.D., director of the Friedman Brain Institute, in a statement. He is also dean of Academic and Scientific Affairs and the Nash Family Professor at Mount Sinai and chief scientific officer of the Mount Sinai Health System. “As AI technology evolves rapidly, this moment is critical to maintaining leadership in digital health. “The Hamilton and Amabel James Center for Artificial Intelligence and Human Health will cultivate an optimal environment for researchers to deepen their understanding, diagnosis and treatment of human diseases, including the most debilitating, and advance overall health and well-being,” he added. .
To build the new AI center, Mount Sinai retrofitted an existing building to meet contemporary standards, including updating the façade to align with the aesthetics of other buildings on campus. Within the center’s 12 floors, eight will be dedicated to Mount Sinai’s AI initiatives. These main facilities include:
• The Windreich Department of AI and Human Health, which focuses on creating an “AI Fabric” that will integrate machine learning and AI-driven decision making across the health system’s eight hospitals.
• The Hasso Plattner Institute for Digital Health at Mount Sinai (HPI•MS), It was formed in 2019 through a collaboration with the Hasso Plattner Institute for Digital Engineering in Germany, which aims to enhance capabilities in data science, biomedical and digital engineering, machine learning, artificial intelligence and wearable technology. In 2024, the Hasso Plattner Foundation renewed its support of HPI•MS for the next five years.
• The Institute of Genomic Health and Division of Medical Genetics, which is leading the effort to harness the power of genomic discovery to develop new ways to prevent and treat diseases, including cancers, heart problems and genetic disorders.
• The Institute of Biomedical Engineering and Imaging, focused on the use of multimodal imaging for brain, heart and cancer research, along with nanomedicine research for precision imaging and drug delivery.
• The Institute of Personalized Medicine, which launched the human genome sequencing research project called the Mount Sinai Million Health Discoveries Program, which aims to enroll 1 million racially and ethnically diverse patients, advance precision medicine research, and improve patient care.
